Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

This study has been terminated.
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center Identifier:
First received: November 10, 2010
Last updated: March 4, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)